ShareValue scores for 900917.SHG: Valuation 80, Quality 39, Growth 33, Health 54.
900917.SHGSSE
Shanghai Haixin Group Co Ltd B
CN¥0.26
(+1.57%)
900917.SHGSSE
Shanghai Haixin Group Co Ltd B
CN¥0.26(+1.57%)
Loading chart...
Sentiment
Verdicts
Value:Undervalued
Quality:Weak
Growth:Weak
Health:Moderate
Verdicts
Fundamental Rating
Value Trap Risk
Expected Return
13% to 29%
Rating
Trap Risk
Return
13% to 29%
Valuation
80
Undervalued
Price vs Value
Quality
39
Weak
Business Strength
Growth
33
Weak
Revenue & Earnings
Health
54
Moderate
Financial Stability
Momentum
47
Neutral
Price Trend
Company Details
About
Shanghai Haixin Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China and internationally. It is also involved in leasing of park properties, financial investment and commodity trading, as well as production and sales of chemical drugs through its sales platform or local distributors; and research and development, production, and sales of plush fabrics and clothing. The company was founded in 1986 and is headquartered in Shanghai, China.
Market Cap$121M
P/E Ratio12.4
Dividend Yield20.49%
Sector Rank#2108
Score Analysis
AI Investment Thesis
Data as of:Jun 29, 2026
|Last calculated:Jun 29, 2026